Literature DB >> 31826311

Irisin Prevents Disuse-Induced Osteocyte Apoptosis.

Giuseppina Storlino1, Graziana Colaianni1, Lorenzo Sanesi1, Luciana Lippo1, Giacomina Brunetti2, Mariella Errede2, Silvia Colucci2, Giovanni Passeri3, Maria Grano1.   

Abstract

Previous results showed that intermittently administered irisin improves bone mass in normal mice and prevents the development of disuse-induced osteoporosis and muscular atrophy in hindlimb-suspended mice, a murine model able to mimic the absence of mechanical loading. A recent study showed that irisin increases survival of osteocytes acting through integrin αV/β5 receptors. To better understand the action of irisin on these cells, we investigated the downstream signaling cascades in osteocyte-like cells (MLO-Y4) treated with recombinant irisin (rec-irisin) in vitro and we analyzed survival of osteocytes and caspase activation in cortical bone of osteoporotic mice treated with rec-irisin in vivo. Our results revealed that rec-irisin activated the MAP kinases Erk1 and Erk2 and increased the expression of the transcription factor Atf4 (2.5-fold, p < .05) through an Erk-dependent pathway in osteocytes. Some key genes expressed by MLO-Y4 cells were modulated by long-term irisin treatment, either continuously administered or given with intermittent short pulses. Interestingly, Sost mRNA was severely downregulated only upon intermittent irisin administration (10-fold, p < .001). Furthermore, rec-irisin upregulated Tfam mRNA (fourfold, p < .05) and Bcl2/Bax ratio (twofold, p < .05) in MLO-Y4 cells. By detecting caspase-9 and caspase-3, we also found that rec-irisin inhibited apoptosis induced by hydrogen peroxide and dexamethasone, respectively. In cortical bone of unloading C57BL6 mice treated with vehicle (unload-veh), irisin prevented disuse-induced reduction of viable osteocytes (+30% versus unload-veh, p < .05) and increase of empty lacunae (+110% versus unload-veh, p < .05), as well as caspase-9 (threefold, p < .05) and caspase-3 (twofold, p < .05) activations. Our findings revealed underlying mechanisms of irisin action on osteocytes, which increases their functions and exerts anti-apoptotic effects, confirming that mechanosensor cells of bone are sensitive to the exercise-mimetic myokine irisin.
© 2019 American Society for Bone and Mineral Research. © 2019 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ANABOLICS; BONE-MUSCLE INTERACTIONS; IRISIN; OSTEOCYTES; OSTEOPOROSIS

Mesh:

Substances:

Year:  2020        PMID: 31826311     DOI: 10.1002/jbmr.3944

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  23 in total

Review 1.  Osteocytes and Cancer.

Authors:  Fabrizio Pin; Matt Prideaux; Lynda F Bonewald; Andrea Bonetto
Journal:  Curr Osteoporos Rep       Date:  2021-11-13       Impact factor: 5.096

2.  Ortho-silicic Acid Plays a Protective Role in Glucocorticoid-Induced Osteoporosis via the Akt/Bad Signal Pathway In Vitro and In Vivo.

Authors:  Guanghui Gu; Dehui Hou; Guangjun Jiao; Wenliang Wu; Hongming Zhou; Hongliang Wang; Yunzhen Chen
Journal:  Biol Trace Elem Res       Date:  2022-03-21       Impact factor: 3.738

3.  Irisin improves delayed bone repair in diabetic female mice.

Authors:  Yuko Kinoshita; Yoshimasa Takafuji; Katsumi Okumoto; Yuto Takada; Hiroki Ehara; Yuya Mizukami; Naoyuki Kawao; Jun-Ichiro Jo; Yasuhiko Tabata; Hiroshi Kaji
Journal:  J Bone Miner Metab       Date:  2022-08-04       Impact factor: 2.976

4.  Fluoride Exposure Provokes Mitochondria-Mediated Apoptosis and Increases Mitophagy in Osteocytes via Increasing ROS Production.

Authors:  Yun Zhang; Fanhe Dong; Zihan Wang; Bingbing Xu; Tao Zhang; Qiqi Wang; Qiao Lin
Journal:  Biol Trace Elem Res       Date:  2022-10-18       Impact factor: 4.081

Review 5.  Bone-Muscle Mutual Interactions.

Authors:  Nuria Lara-Castillo; Mark L Johnson
Journal:  Curr Osteoporos Rep       Date:  2020-08       Impact factor: 5.096

Review 6.  FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective.

Authors:  Patrizia Pignataro; Manuela Dicarlo; Roberta Zerlotin; Chiara Zecca; Maria Teresa Dell'Abate; Cinzia Buccoliero; Giancarlo Logroscino; Silvia Colucci; Maria Grano
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

Review 7.  Bone and Muscle Crosstalk in Aging.

Authors:  Chen He; Wenzhen He; Jing Hou; Kaixuan Chen; Mei Huang; Mi Yang; Xianghang Luo; Changjun Li
Journal:  Front Cell Dev Biol       Date:  2020-12-10

8.  The Effects of 8-Week Resistance and Endurance Trainings on Bone Strength Compared to Irisin Injection Protocol in Mice.

Authors:  Shirin Shahabi; Fahimeh Esfarjani; Jalil Reisi; Sedigheh Momenzadeh; Mohammad-Saeid Jami; Saeed Zamani
Journal:  Adv Biomed Res       Date:  2021-11-26

Review 9.  Progress and Challenges in the Biology of FNDC5 and Irisin.

Authors:  Steffen Maak; Frode Norheim; Christian A Drevon; Harold P Erickson
Journal:  Endocr Rev       Date:  2021-07-16       Impact factor: 19.871

Review 10.  Osteocyte apoptosis: the roles and key molecular mechanisms in resorption-related bone diseases.

Authors:  Jiang-Ying Ru; Yan-Fen Wang
Journal:  Cell Death Dis       Date:  2020-10-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.